DFX Intelligence
Nutrivert Inc.
Venture-backed company · Stage unknown· Atlanta, GA
As of · the latest observation of this company; each round carries its own date
Form D industry: Pharmaceuticals
As of · the latest observation of this company; each round carries its own date
What matters now
- $2.37Msold on Form D
Filed a Form D on 10 Apr 2026: $2.37M sold on Form D. A Form D is an offering filing; it names no investors, stage or valuation.
A company that just raised has fresh capital, a new board and new vendors to choose.
- 1 directorboard
1 director on record from Form D filings and board-seat attributions.
The board is who decides on the next round and on a sale.
Drawing the relationship network…
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- Decline to Disclosesec.gov
- Rounds on record
- 1
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 0
Financing history
1 round
- Apr 10, 2026Form D equity offering · $2.4M (form d sold) · 2 investorsFact Form D · “Nutrivert Inc. filed Form D: $2,374,992 sold of $5,999,989, Pharmaceuticals”
Investors on record
0 edges
No named investor yet.
Ownership and outcomesHow these are wordedA company a buyout or growth firm lists on its own site is “listed in the portfolio of”, never “acquired by”. A date prints only when a deal record gives one; otherwise the row says when DFX first saw it.
none on record
No later owner or exit on record: no private equity sponsor position and no acquisition, listing or IPO report names this company.
Credit relationshipsHow a loan is matchedA BDC reports its loans by borrower name. A position shows here only when the match passed a precision gate (a hand-labelled sample was 29 of 30 correct); the tier and confidence are printed on each row. Amounts are the lender’s reported position, never a round.
none on record
No lender position matched to this company.
People
3 officers, 1 director
- Bernhard Kaltenboeck Executive Officer/Director sec.gov
- Horace Nalle Executive Officer/Director sec.gov
- Peter Selover Executive Officer/Director sec.gov
- Troy Merry Director Fact
Timeline
1 event
- Apr 29, 2026Nutrivert Inc. filed Form D: $2,374,992 sold of $5,999,989, PharmaceuticalsForm D filed Fact Form D
Evidence
14 observations
Every observation on this company
- Entity type: Corporation Apr 29, 2026 Fact Form D
- Form D industry group: Pharmaceuticals Apr 29, 2026 Fact Form D
- Amendment: false Apr 29, 2026 Fact Form D
- Revenue range (Form D): Decline to Disclose Apr 29, 2026 Fact Form D
- Incorporated: overFiveYears Apr 29, 2026 Fact Form D
- Jurisdiction: Delaware Apr 29, 2026 Fact Form D
- Amount sold (Form D): $2.4M Apr 29, 2026 Fact Form D
- Offering amount (Form D): $6.0M Apr 29, 2026 Fact Form D
- Exemptions: 06b Apr 29, 2026 Fact Form D
- First sale: 2026-04-10 Apr 29, 2026 Fact Form D
- Investors (Form D): 2 Apr 29, 2026 Fact Form D
- Minimum investment (Form D): 0 Apr 29, 2026 Fact Form D
- Securities offered: equity Apr 29, 2026 Fact Form D
- Office address: Apr 29, 2026 Fact Form D
Record history
1 dated event on the change ledger, latest event first
- Form D filed2026-04-29source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.